Correlation Between Mind Medicine and Chemours
Can any of the company-specific risk be diversified away by investing in both Mind Medicine and Chemours at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mind Medicine and Chemours into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mind Medicine and Chemours Co, you can compare the effects of market volatilities on Mind Medicine and Chemours and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mind Medicine with a short position of Chemours. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mind Medicine and Chemours.
Diversification Opportunities for Mind Medicine and Chemours
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mind and Chemours is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Mind Medicine and Chemours Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chemours and Mind Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mind Medicine are associated (or correlated) with Chemours. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chemours has no effect on the direction of Mind Medicine i.e., Mind Medicine and Chemours go up and down completely randomly.
Pair Corralation between Mind Medicine and Chemours
Given the investment horizon of 90 days Mind Medicine is expected to generate 1.57 times more return on investment than Chemours. However, Mind Medicine is 1.57 times more volatile than Chemours Co. It trades about 0.06 of its potential returns per unit of risk. Chemours Co is currently generating about 0.0 per unit of risk. If you would invest 262.00 in Mind Medicine on September 12, 2024 and sell it today you would earn a total of 453.00 from holding Mind Medicine or generate 172.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mind Medicine vs. Chemours Co
Performance |
| Timeline |
| Mind Medicine |
| Chemours |
Mind Medicine and Chemours Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mind Medicine and Chemours
The main advantage of trading using opposite Mind Medicine and Chemours positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mind Medicine position performs unexpectedly, Chemours can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will offset losses from the drop in Chemours' long position.| Mind Medicine vs. Cybin Inc | Mind Medicine vs. Seelos Therapeutics | Mind Medicine vs. GH Research PLC | Mind Medicine vs. Awakn Life Sciences |
| Chemours vs. Griffon | Chemours vs. Merck Company | Chemours vs. Brinker International | Chemours vs. Alcoa Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |